Epidemiologic studies are crucial to the estimation of numbers of deaths attributable to air
pollution. In this paper, the authors present a framework for distinguishing estimates of …

… ) increases by 10 μg/m 3·3 Given the finite resources available to protect health, there is a
need to weight different risks and to allocate … We divided exposure into categories of 5 μg/m …

… 80–100 mg/m 2 on days 1–3 of each cycle with investigator's choice of either carboplatin
area under the curve 5–6 mg/mL per min or cisplatin 75–80 mg/m 2 (administered on day 1 of …

Background Never smokers comprise a substantial proportion of patients with COPD. Their
characteristics and possible risk factors in this population are not yet well defined. Methods …

… etoposide 80–100 mg/m 2 on days 1–3 of each cycle with investigator's choice of either
carboplatin area under the curve 5–6 mg/mL/min or cisplatin 75–80 mg/m 2 on day 1 of each …

BACKGROUND COPD ranks within the top three causes of mortality in the global burden of
disease, yet it remains largely underdiagnosed. We assessed the underdiagnosis of COPD …

Introduction Electromagnetic navigation bronchoscopy (ENB) is a minimally invasive technology
that guides endoscopic tools to pulmonary lesions. ENB has been evaluated primarily …

Immune checkpoint inhibitors are antibodies, which enhance cellular and humoral immune
responses and are approved for the treatment of various tumors. Immune-related adverse …

Background:COPD is projected to be the third leading cause of death worldwide by 2020.
The Burden of Obstructive Lung Disease initiative was started to measure the prevalence of …

Background Chronic obstructive pulmonary disease (COPD) is a commonly reported cause
of death and associated with smoking. However, COPD mortality is high in poor countries …